FDA warned hospitals about security risk with 2 models of Hospira drug infusion pumps | Regulatory news for the week of May 18, 2015

Here's a look at some of the top regulatory stories for medical device companies this week: FDA warns on Hospira pumps after researcher reveals security flaws; Latest data from Health Canada on MDL screening deficiencies, additional information requests; Arterial Remodeling wins CE Mark for bioreabsorbable stent; FDA guidance outlines principles for adaptive design in device clinical trials

FDA warns on Hospira pumps after researcher reveals security flaws

May 14, 2015 by Brad Perriello

Arterial Remodeling Technologies, Emergo Group, Food & Drug Administration (FDA), Hospira Inc.

News Well, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AiKQLB